首页> 外文期刊>The Journal of dermatology >Six novel mutations of the ADAR1 gene in patients with dyschromatosis symmetrica hereditaria: histological observation and comparison of genotypes and clinical phenotypes.
【24h】

Six novel mutations of the ADAR1 gene in patients with dyschromatosis symmetrica hereditaria: histological observation and comparison of genotypes and clinical phenotypes.

机译:对称性色异常患者的ADAR1基因的六个新突变:组织学观察和基因型与临床表型的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

Dyschromatosis symmetrica hereditaria (DSH), is a pigmentary genodermatosis of autosomal dominant inheritance. Since we clarified that the disease is caused by a mutation of the adenosine deaminase acting on the RNA 1 gene (ADAR1) in 2003, the molecular pathogenesis of a peculiar clinical feature of the disease has been expected to be clarified. We examined five familial cases and one sporadic case of Japanese families with DSH. The mutation analyses were done with single-strand conformation polymorphism/heteroduplex (SSCP/HD) analysis and direct sequencing of ADAR1. The DNA analysis of each patient revealed one missense mutation (p.F1091S), two nonsense mutations (p.C893X, p.S581X) and three frame-shift mutations (p.E498fsX517, p.F1091fsX1092, p.L855fsX856). Visual and electron microscopic findings showed abundant melanin pigment deposited all over the basal layer, and enlarged melanocytes with long dendrites located in the pigmented lesions with small or immature melanosomes scattered sparsely in thecytoplasm, but in the adjacent keratinocytes many small melanosomes were singly dispersed or aggregated. The hypopigmented areas showed little melanin deposition and reduced numbers of melanocytes in which much degenerative cytoplasmic vacuole formation could be observed by electron microscopy. Herein, we report six cases of DSH with six novel mutations. The variety of their clinical phenotypes even in the pedigree may suggest the presence of factors other than the ADAR1 gene influencing the extent of the clinical skin lesion. Microscopic findings suggest that the clinical appearance must have developed directly by melanocyte variations mainly induced by the ADAR1 gene mutations.
机译:对称性色素沉着病(DSH),是常染色体显性遗传的色素性皮肤病。由于我们在2003年阐明该疾病是由作用于RNA 1基因(ADAR1)的腺苷脱氨酶的突变引起的,因此该疾病特有临床特征的分子发病机理已有望得到阐明。我们研究了5例日本DSH家庭家族病例和1例散发性病例。使用单链构象多态性/异源双链(SSCP / HD)分析和ADAR1的直接测序进行突变分析。每个患者的DNA分析显示一个错义突变(p.F1091S),两个无义突变(p.C893X,p.S581X)和三个移码突变(p.E498fsX517,p.F1091fsX1092,p.L855fsX856)。视觉和电子显微镜检查结果显示,黑色素大量沉积在整个基底层上,黑色素细胞长大,分布在色素沉着的病变中,黑色或小或不成熟的黑素体稀疏地散布在细胞质中,但在相邻的角质形成细胞中,许多小的黑色素单个地分散或聚集。色素沉着不足的区域显示出很少的黑色素沉积,黑色素细胞数量减少,通过电子显微镜可以观察到许多变性细胞质液泡形成。在此,我们报告了6例具有6个新突变的DSH病例。即使在血统书中,其临床表型也可能多种多样,这表明存在除ADAR1基因以外的其他因素会影响临床皮肤病变的程度。显微镜下的发现提示,临床现象必须直接由主要由ADAR1基因突变诱导的黑素细胞变异形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号